R. Mohle et al., ESTIMATION OF THE PROGENITOR-CELL YIELD IN A LEUKAPHERESIS PRODUCT BYPREVIOUS MEASUREMENT OF CD34-BLOOD( CELLS IN THE PERIPHERAL), Vox sanguinis, 71(2), 1996, pp. 90-96
To assess whether measurement of CD34+ cells in the peripheral blood a
llows one to estimate the progenitor cell yields of subsequent leukaph
eresis procedures, 733 corresponding blood and leukapheresis samples w
ere analyzed. Peripheral blood progenitor cells of cancer patients wer
e mobilized with hematopoietic growth factors alone or postchemotherap
y, and harvested processing 10 liters of blood for each leukapheresis
product. The CD34+ cell count (CD34+ cells/mu l blood) correlated most
closely with the progenitor cell yield in the corresponding leukapher
esis product (CD34+ cells/kg bodyweight, r = 0.80), while the proporti
on of circulating CD34+ cells to the white blood and mononuclear cells
predicted the yield less reliably (r = 0.74 and r = 0.60). The CD34cell yield was independent of the white blood count (r = 0.04), wherea
s a weak correlation was found between the mononuclear cell count and
the number of CD34+ cells/kg collected (r = 0.42). It was unlikely to
obtain the threshold quantity of 2.5 x 10(6) CD34+ cells/kg required f
or rapid engraftment when counts below 10 CD34+ cells/mu l blood were
detected. At levels between 10 and 30 CD34+ cells/mu l sufficient auto
grafts could be harvested, whereas 30-100 CD34+ cells/mu l were requir
ed to achieve this by a single leukapheresis. A surplus of CD34+ cells
was likely above 100 CD34+ cells/mu l which could be useful for proge
nitor cell enrichment techniques, The correlation between the CD34+ ce
ll count and progenitor cell yield was independent of the mobilizing r
egimen and whether leukaphereses had been performed previously. In con
clusion, the number of CD34+ cells/mu l blood allows a reliable predic
tion of the CD34+ progenitor cell yield in subsequent leukapheresis pr
ocedures. However, rare cases of unexpectedly sufficient progenitor ce
ll yields may be observed even at CD34+ cell levels below detection li
mit.